Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02568865 · ClinicalTrials.gov registry record
Noninvasive Physiologic Sensors to Assess Depression
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 50
- Enrollment target
NCT02568865: Completed study, sponsored by Massachusetts General Hospital.
NCT02568865 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02568865 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This project aims to use sensors to monitor physiological signals, sleep patterns, vocal characteristics, activity, location and phone usage in study patients with depression who are receiving standard treatment (compared with healthy controls).
Primary Outcome
We will measure the heart rate at baseline and during the treatment period. We will compare the corresponding patterns in patients with depression, as well as in healthy controls.
Interventions
- OTHER Physiological Sensors
- OTHER Sleep Monitoring Device
- OTHER Vocal Monitoring
- OTHER Mobile Phone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-01-15 |
| Est. Completion | 2020-01-03 |
What the finished NCT02568865 record still lists
NCT02568865 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Physiological Sensors is the first listed.
NCT02568865 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02568865 about?
NCT02568865 is a clinical study titled "Noninvasive Physiologic Sensors to Assess Depression". This project aims to use sensors to monitor physiological signals, sleep patterns, vocal characteristics, activity, location and phone usage in study patients with depression who are receiving standard treatment (compared with healthy controls).
What is the current status of trial NCT02568865?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2016-01-15. Estimated completion is 2020-01-03.
What interventions are being tested in trial NCT02568865?
The interventions under investigation include: Physiological Sensors (OTHER), Sleep Monitoring Device (OTHER), Vocal Monitoring (OTHER), Mobile Phone (OTHER).
Who is sponsoring clinical trial NCT02568865?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI